Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer.
Soichiro AkoHironari KatoKazuhiro NousoHideaki KinugasaHiroyuki TerasawaHiroshi MatushitaSaimon TakadaYosuke SaragaiSho MizukawaShinichiro MuroDaisuke UchidaTakeshi TomodaKazuyuki MatsumotoShigeru HoriguchiDaisuke NobuokaRyuichi YoshidaYuzo UmedaTakahito YagiHiroyuki OkadaPublished in: Cancer biology & therapy (2021)
In patients with PDAC, detection of KRAS mutations in plasma proved independently predictive of early recurrence after surgical resection but did not correlate with PFS following chemotherapy.